Accelerating mRNA Technology Through Automation
Penn Launches $18M AI-Driven RNA BioFoundry
The NSF-funded AIRFoundry uses automation and AI to accelerate mRNA drug delivery and therapy research.
A wide-angle view of a modern laboratory with robotic automation systems and liquid handling stations used for RNA research.
Photo: Avantgarde News
The University of Pennsylvania recently celebrated the opening of the NSF Artificial Intelligence-driven RNA BioFoundry, known as AIRFoundry [1]. This $18 million facility focuses on using AI and automation to design and test lipid nanoparticles for RNA-based therapies [1][3]. The hub aims to democratize access to mRNA technology by reducing the trial-and-error often found in drug development [1][2].
Located at One uCity Square, the center integrates high-throughput experiments with machine learning models [3]. Researchers use these tools to synthesize and evaluate delivery vehicles for genetic medicines [2]. By streamlining the research process, the facility hopes to make advanced medical treatments more accessible to scientists globally [1][3].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
Related stories
View all
Topics
About the author
Avantgarde News Desk covers accelerating mrna technology through automation and editorial analysis for Avantgarde News.